Peers of Vitaspring Biomedical Co. Ltd (VSBC)
Side-by-side comparison
Health Care · Biotechnology
Enterprise value divided by trailing twelve-month EBITDA. A popular valuation multiple that is capital-structure neutral.
Latest EV/EBITDA
-20.38x
As of Oct 8, 2026
Beyond EV/EBITDA, the valuation view includes forward multiples, EV ratios, cash flow yields, and multi-year chart history for further research.
| Date | EV/EBITDA |
|---|---|
| Oct 8, 2026 | -20.38x |
| Feb 12, 2026 | -5.14x |
| Jan 27, 2026 | -88.69x |
| Mar 5, 2025 | -303.92x |
| Mar 4, 2025 | -303.92x |
| Feb 26, 2025 | -60.78x |
| Feb 19, 2025 | -54.71x |
| Jan 28, 2025 | -38.12x |
EV/EBITDA = Enterprise Value / EBITDA (TTM). Enterprise Value = Market Cap + Total Debt − (Cash & Short-Term Investments + Long-Term Investments).
EV/EBITDA is widely used because it removes the effects of financing and non-cash accounting items.
Read the general EV/EBITDA definition, formula, and analyst usage guide.
EV/EBITDA guideInformational research only; not personalized advice. Values reflect the latest available data on Chartloom and may differ from other sources.
Side-by-side comparison